Titlebook: Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease; Therapeutic & Theran Abha Sharma,Gyan Prakash Modi Book 2023 The Edi

HABIT

書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease影響因子(影響力)




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease影響因子(影響力)學(xué)科排名




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease網(wǎng)絡(luò)公開度




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease被引頻次




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease被引頻次學(xué)科排名




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease年度引用




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease年度引用學(xué)科排名




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease讀者反饋




書目名稱Natural Product-based Synthetic Drug Molecules in Alzheimer‘s Disease讀者反饋學(xué)科排名

出血

Oxidative Stress and Metals in Alzheimer’s Diseasefects the elderly population. Key pathological hallmarks of AD are extracellular depositions of beta-amyloid plaques, intracellular accumulation of neurofibrillary tangles (NFTs), and alterations in amyloid precursor protein (APP) gene, and it is clinically characterised by changes in cellular and m

Nonconformist

Neuroinflammation in Alzheimer’s Diseaseelderly individuals. Mild-to-severe extent of neurodegeneration triggers AD in most cases. Patients with AD carry a higher chance of generation of dementia, memory loss, and gradual loss of basic intellect. According to a recent report, calcium dysfunction at the neuron level and microglia-mediated

頑固

Medicare

neolith

babble

Approved Cholinesterase Inhibitor-Based Derivatives: Synthesis and Their Biological Evaluationchers. Alzheimer’s disease (AD) is one such disease that involves multiple largely ambiguous pathophysiological pathways, which makes it a challenging thrust area of research around the globe. The current approved drugs for the management of the disease include rivastigmine, donepezil, galantamine (

鍵琴

教唆

heartburn

Polyphenol: Development of Polyphenol-Inspired Derivatives Targeting Pathological Factors of ADs. Polyphenolic compounds, a class of natural plant compounds, have been extensively studied for their potential therapeutic use in AD. The neuroprotective, antioxidant, as well as anti-inflammatory properties exhibited by these compounds are important in the treatment and management of AD. Phenolic